| Stephen S. Schwartz |
CEO, Director |
$25.9 M |
|
|
Nov 15, 2023 |
| Jason Joseph |
SVP, General Counsel, Secy. |
$11.8 M |
|
|
Apr 1, 2024 |
| Lindon Robertson |
EVP & Chief Financial Officer |
$7.02 M |
|
|
Nov 15, 2023 |
| Mark S. Wrighton |
Director |
$6.48 M |
|
|
Feb 11, 2022 |
| Krishna G. Palepu |
Director |
$6.11 M |
|
|
Feb 13, 2023 |
| William T. Montone |
SVP, Human Resources |
$5.33 M |
|
|
Sep 27, 2021 |
| Joseph R. Martin |
Director |
$4.94 M |
|
|
Jun 6, 2023 |
| David C. Gray |
Chief Strategy & New Business |
$4.34 M |
-$1.22 M |
-22% |
Nov 17, 2023 |
| Robyn Davis |
Director |
$3.52 M |
|
|
Feb 12, 2024 |
| Robin Vacha |
SVP, GM Life Science Products |
$3.03 M |
|
|
Feb 1, 2024 |
| David Jarzynka |
President, Semi Solutions |
$2.68 M |
|
|
Nov 19, 2021 |
| Ellen M. Zane |
Director |
$2.38 M |
|
|
Aug 8, 2023 |
| Matthew McManus |
EVP & Chief Operating Officer |
$1.67 M |
|
|
Aug 19, 2022 |
| David Pietrantoni |
Principal Accounting Officer |
$1.59 M |
|
|
Nov 17, 2021 |
| Michael Rosenblatt |
Director |
$1.47 M |
|
|
Feb 12, 2024 |
| Erica McLaughlin |
Director |
$1.45 M |
|
|
Feb 12, 2024 |
| Ginger Zhou |
SVP and General Manager, Genom |
$1.23 M |
|
|
Feb 1, 2024 |
| Frank Casal |
Director |
$955 K |
|
|
Feb 12, 2024 |
| Herman Cueto |
EVP, Chief Financial Officer |
$863 K |
|
|
Nov 16, 2023 |
| Tina Susan Nova |
Director |
$609 K |
|
|
Feb 12, 2024 |
| David D. Wang |
Svp & Gm, Sms |
$549 K |
|
|
Dec 1, 2023 |
| Kimberly Crowley |
SVP, Chief HR Officer |
$429 K |
|
|
Jan 31, 2023 |
| Violetta Hughes |
VP, Chief Accounting Officer |
$398 K |
|
|
May 20, 2024 |
| Vandana Sriram |
SVP Finance & Corp. Controller |
$368 K |
|
|
Jan 31, 2023 |
| Dorothy Puhy |
Director |
$204 K |
|
|
Feb 13, 2023 |
| Olga Pirogova |
SVP and CHRO |
$182 K |
|
|
Nov 16, 2023 |
| Martin D. Madaus |
Director |
$163 K |
|
|
Feb 12, 2024 |
| Edward P. Bousa |
Director |
$163 K |
|
|
Feb 12, 2024 |
| Didier Hirsch |
Director |
$163 K |
|
|
Feb 12, 2024 |
| Linda De Jesus |
Chief Commercial Officer, LS |
$156 K |
|
|
Jul 29, 2022 |
| Mitchell Coyne |
SVP and GM, Life Sciences Proj |
$109 K |
|
|
Nov 17, 2022 |
| Alfred Woollacott III |
Director |
|
|
|
Dec 23, 2021 |